Evidence map›Paper›PMID 40399466›Full record

ArticleScientific reports2025

Utilizing rewards to dampen fear and its recovery.

Elliot C Brown, Sergio Oroz Artigas, Sarah Elsner, Lu Liu, Soyoung Q Park

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Elliot C BrownDepartment of Decision Neuroscience and Nutrition, German Institute of Human Nutrition (DIfE), 14558, Nuthetal, Germany.
Sergio Oroz ArtigasDepartment of Psychology I, University of Lübeck, 23562, Lübeck, Germany.
Sarah ElsnerDepartment of Psychology I, University of Lübeck, 23562, Lübeck, Germany.
Lu LiuDepartment of Psychology, Sun Yat-sen University, 510006, Guangzhou, China. liulu86@mail.sysu.edu.cn.
Soyoung Q ParkDepartment of Decision Neuroscience and Nutrition, German Institute of Human Nutrition (DIfE), 14558, Nuthetal, Germany. soyoung.q.park@gmail.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Fearful memories can be extinguished by repeated exposure, without aversive outcomes. Fear extinction as the basis for exposure therapy, is a common treatment for anxiety and fear-related disorders, but it can be unpleasant and does not always work. In two independent studies, we investigated whether a novel compound extinction procedure (simultaneous presentation of a rewarded and a feared stimulus, reward-fear deepened extinction) attenuates fear while tracking physiological, neural and subjective changes in pleasantness. The reward-fear deepened extinction showed comparable effects to the fear-fear deepened extinction (two-fear compound extinction) in effectively enhancing fear extinction and protecting against the return of fear 1 week later. Moreover, fear extinction accompanying a reward cue was perceived as more pleasant. On the neural level, we identified a network involving hippocampus and amygdala that underlies the benefit of deepened extinction, where connectivity changes also predicted changes in subjective pleasantness. Our study identifies the effects of deepened extinction in regulating long-term fear recovery and its underlying neural mechanism. We shed light on an innovative method to enhance fear extinction, with high translational potential for therapy.

Indexed as

Extinction, PsychologicalFearRewardAdultAmygdalaConditioning, ClassicalFemaleHippocampusHumansMagnetic Resonance ImagingMaleYoung AdultDeepened extinctionFear reinstatementHippocampusReward–fear extinctionSkin conductance responses

Identifiers

PMID40399466
PMCPMC12095787

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.